Hangzhou Tigermed Consulting Co. Ltd. considered and approved appointment of Ms. Yang Chengcheng as the chief financial officer of the Company.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
55.33 CNY | +0.76% | -2.91% | +0.65% |
Apr. 25 | Hangzhou Tigermed Consulting’s Profit Down 59% in Q1 | MT |
Apr. 25 | Hangzhou Tigermed Consulting Co., Ltd Reports Earnings Results for the First Quarter Ended March 30, 2024 | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+0.65% | 6.14B | |
+67.53% | 63.85B | |
-0.77% | 41.83B | |
+44.98% | 40.65B | |
-10.87% | 27.12B | |
+13.30% | 26.52B | |
-22.79% | 18.69B | |
+4.70% | 12.73B | |
+24.10% | 12.11B | |
+27.41% | 12.07B |
- Stock Market
- Equities
- 300347 Stock
- News Hangzhou Tigermed Consulting Co., Ltd
- Hangzhou Tigermed Consulting Co., Ltd Approves Appointment of Ms. Yang Chengcheng as the Chief Financial Officer